The Impact of TORasemide oN hemodynAmic and Neurohormonal Stress, and carDiac remOdeling in Heart Failure
A phase 4 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 100 participants.
Also called NCT01942109
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; double masking; primary purpose treatment
- Phase
- Phase 4
- Enrolled
- 100 participants
- Sponsor
- Registry
-
NCT01942109
-
- Start date
- (registry gives no type)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- Poland
- Registry status
- Unknown status
Technical summary
Registry record NCT01942109. Randomized; double masking; primary purpose treatment. Start 2013-09 (registry gives no type); primary completion 2017-12 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- The Impact of TORasemide oN hemodynAmic and Neurohormonal Stress, and carDiac remOdeling in Heart Failure
- Acronym
- TORNADO
- Condition
- Heart Failure
- Intervention (Drug)
- Furosemide
- Intervention (Drug)
- Torasemide
- Lead sponsor
- Medical University of Warsaw
Record details
- Record id
cardio:ct-nct01942109- Content hash
8173e6e8897224702bb2866d3e21c1b9b281aae24fdfc365cb576fb0bb492d3c